8月13日，2025年中国国际服务贸易交易会（以下简称"服贸会"）健康卫生服务专题媒体通气会在国家 会议中心举办。北京商报记者从现场了解到，本次服贸会将于9月10日—14日在京举办，健康卫生服务 专题以"智领未来，健康生活"为年度主题，设置"智疗云枢前瞻矩阵""全民健康服务矩阵"两大展示体验 区，同期举办包括首都国际医学大会在内的近20场会议论坛及配套活动。一些具有先进技术和市场影响 力的产品将通过服贸会平台进行全球首发、中国首展，全面展示人工智能与医疗健康融合的创新成果。 场景化呈现生物医药AI研发全流程 北京市卫生健康委员会一级巡视员郑晋普在会上介绍，健康卫生服务专题展设置了"智疗云枢前瞻矩 阵""全民健康服务矩阵"两大展示体验区。目前，招商招展工作已经全部完成，邀请世界500强及行业龙 头企业参展率达到了54%，国际化率达53%。一些具有先进技术和市场影响力的产品将通过服贸会平台 进行全球首发、中国首展。此外，专题展区还将举办系列签约洽谈、成果发布活动。 两大展示体验区之外，本届健康卫生服务专题还将同期在首钢园举办"首都国际医学大会"等近20场各类 会议、论坛和配套活动。 据中国医院协会常务副会长毛群安 ...

据上证报报道，8月13日，浙江省卫生健康委员会等10部门印发《浙江省加快推动"人工智能+医疗健 康"高质量发展行动计划》。其中提到，打造多模态医疗行业大模型，建设全自主AI研发框架，形成共 性模型服务能力。开发覆盖医疗服务、健康管理、公共卫生、药械研发、行业治理等一批专病专科模型 和医疗智能体。聚焦人工智能数据与应用、脑机接口、新药创制等领域部署实施重大科技专项，加强多 模态人工智能、具身智能与医学、药学交叉领域的科研布局。鼓励科研机构加强医学人工智能跨学科合 作，形成一批具有全球影响力的科研成果。 另外，8月12日，国家医保局公示通过2025年医保目录及商保创新药目录调整初步形式审查的药品及相 关信息。根据公告，今年共有534个药品通过基本医保目录的形式审查，121个药品通用名通过商保创新 药目录的形式审查，包括定价百万元的抗癌药CAR-T在内，多款高价创新药冲刺商保创新药目录，寻求 创新药多元支付的新途径。 方正证券表示，"人工智能+"驱动医疗产业革命性发展，脑机接口、手术机器人等高端创新设备加速落 地和应用拓展。脑机接口(BCI)商业转化持续加速，受国内监管审批对安全、伦理的高要求，以及产业 发展优先推 ...

Group 1: First Store Economy Development - Zhejiang Province has launched a three-year action plan (2025-2027) to accelerate the development of the first store economy, aiming to invigorate urban commercial vitality, promote consumption transformation, and enhance the quality of life for residents [2][3] - The action plan targets the addition of over 2,000 new urban brand first stores by 2027, including 200 high-level first stores in the East China region, and the establishment of over 50 first store clusters and incubation areas [2][3] - The plan emphasizes attracting high-quality product first stores in key areas such as smart home, digital electronics, and cultural creative products, with a goal of adding over 1,000 new product brand first stores by 2027 [2][3] Group 2: Service Innovation and Experience - The action plan encourages the introduction and cultivation of innovative service first stores in sectors like leisure, creative dining, cultural tourism, health care, and education, aiming to add over 1,000 new service brand first stores by 2027 [3] - It promotes the development of immersive and interactive consumption experiences through innovative space design and operational models in service first stores [3] Group 3: Optimizing Business Environment - The action plan outlines measures to optimize the business environment for first stores, including streamlining administrative processes and improving approval efficiency for brand entry and operations [4] - It aims to implement integrated services for first store operations, promoting online and offline service collaboration [4] Group 4: Artificial Intelligence in Healthcare - Zhejiang Province has also introduced an action plan (2025-2027) to promote the high-quality development of "Artificial Intelligence + Healthcare," aiming to establish a national AI medical application base [5][6] - The plan sets a goal to build a medical AI ecosystem by 2027, including the development of over 50 high-quality industry-specific databases and the breakthrough of more than 10 core medical AI technologies [5][6] - It emphasizes the integration of AI in public health services and future hospitals, focusing on personalized health services and enhancing hospital management and clinical research [6][7]

Group 1: Core Views - Zhejiang Province has launched a three-year action plan (2025-2027) to accelerate the development of the "first store economy," aiming to invigorate urban commercial vitality and enhance consumer experience [2][3][4] - The plan targets the establishment of over 2,000 new urban brand first stores by 2027, including 200 high-level first stores in the East China region [3][4] Group 2: Specific Measures for First Store Economy - The action plan includes 12 specific measures focusing on attracting high-quality product first stores, particularly in smart home, digital electronics, and cultural creative sectors [3][4] - It aims to introduce 1,000 new product brand first stores by 2027, encouraging traditional stores to upgrade into flagship and innovative concept stores [3][4] Group 3: Service Sector Development - The plan emphasizes the cultivation of innovative service first stores in leisure, creative dining, cultural tourism, health care, and education sectors, targeting the introduction of 1,000 new service brand first stores by 2027 [4][6] - It encourages the development of immersive experience stores and digital service spaces, aligning with trends in "AI + consumption" [4][6] Group 4: Optimizing Business Environment - The action plan proposes to streamline government services related to the first store economy, enhancing approval efficiency and simplifying processes for brand entry and operation [5][6] - It includes initiatives like "one-stop service" and "online-offline service collaboration" to facilitate the establishment of first stores [5][6] Group 5: Artificial Intelligence in Healthcare - Concurrently, Zhejiang has introduced an action plan for the high-quality development of "AI + healthcare," aiming to establish a national AI medical application base by 2027 [6][7] - The plan targets the creation of over 50 high-quality industry-specific databases and the development of more than 10 core AI medical technologies [6][7] Group 6: Future Hospital Innovations - The action plan outlines the integration of AI in future hospitals, focusing on enhancing diagnostic techniques, service experiences, and hospital management through emerging technologies [7][8] - It encourages collaboration between enterprises and research institutions to foster innovation in AI and healthcare sectors [7][8]

Group 1 - The 2025 China International Service Trade Fair (CIFTIS) will be held from September 10 to 14 in Beijing, featuring a health and wellness services section with a participation rate of 54% from Fortune Global 500 and industry-leading companies, and an internationalization rate of 53% [1][2] - The health and wellness services section will include two major experience zones: "Intelligent Therapy Cloud Matrix" and "National Health Service Matrix," showcasing advanced technologies and products such as the national AI application pilot project and small-scale meridian conditioning robots [2][3] - Notable participants include global leaders like GE Healthcare, Siemens Healthineers, and Mindray, with new entrants like Elsevier and specialized companies such as Naton Technology and TuPai Medical [2][3] Group 2 - In the field of traditional Chinese medicine (TCM), 48 institutions will participate, with 27 offline exhibitors, marking a record high participation rate of 48% from leading organizations like Tongrentang and the China Academy of Chinese Medical Sciences [3] - The event will also host the Capital International Medical Conference, focusing on topics such as technology innovation, healthcare industry development, and global health governance, along with the release of influential research reports [3][4] - The health and wellness services section will highlight "Beijing Service" brand cases, including Siemens' photon-counting CT and AstraZeneca's $2.5 billion investment in a new strategic R&D center in Beijing [4]

Group 1 - The A-share market is experiencing a surge in the pharmaceutical sector, particularly in innovative drugs, with Hai Si Ke reaching its daily limit and Di Zhe Pharmaceutical rising over 8% [1] - The National Healthcare Security Administration has announced the preliminary review of 121 drug names for inclusion in the commercial insurance innovative drug directory, including high-priced CAR-T cancer drugs [1] - The medical sector is seeing a rebound driven by CXO, with the largest medical ETF (512170) hitting a 1.9% increase, and major stocks like Zhaoyan New Drug rising over 8% [3] Group 2 - A new action plan for the high-quality development of "Artificial Intelligence + Healthcare" in Zhejiang Province has been released, focusing on creating multimodal medical industry models and specialized healthcare models [5] - Recent institutional insights suggest that the pharmaceutical sector, led by innovative drugs, is viewed positively for long-term investment, while medical devices are also gaining attention [5] - The largest medical ETF (512170) focuses on medical devices (52%) and medical services (40%), with a strong correlation to AI healthcare, covering six leading CXO stocks [6]

Group 1 - The A-share market is experiencing a surge in the pharmaceutical sector, particularly in innovative drugs, with HaiSiKe reaching its daily limit and DiZhe Pharmaceutical rising over 8% [1] - The National Healthcare Security Administration has announced the preliminary review of 121 innovative drugs for inclusion in the commercial insurance innovative drug directory, including high-priced CAR-T cancer drugs [1] - The pharmaceutical ETF (562050) has seen a 2% increase, reflecting strong market interest in the sector [1] Group 2 - The healthcare sector is showing positive momentum, driven by CXO companies, with the largest medical ETF (512170) rising by 1.9% and significant gains in stocks like ZhaoYan Pharmaceutical and WuXi AppTec [2] - Recent capital inflows into the medical ETF indicate a recovery trend, with over 360 million yuan attracted in three out of the last four trading days [2] - A new action plan from the Zhejiang Provincial Health Commission aims to accelerate the development of "AI + healthcare," focusing on creating multimodal medical models and intelligent healthcare systems [4] Group 3 - Analysts are optimistic about the pharmaceutical sector, particularly innovative drugs and medical devices, suggesting that leading pharmaceutical companies are poised for value reassessment [4] - The unique pharmaceutical ETF (562050) focuses on the top 50 pharmaceutical companies, with 60% of its holdings in innovative drugs, while the largest medical ETF (512170) emphasizes medical devices and services [4]

Core Viewpoint - The 2025 China International Service Trade Fair will feature a health and wellness service theme, showcasing innovations in healthcare technology and services, with a focus on artificial intelligence in medical applications [1][2]. Group 1: Event Overview - The event will take place from September 10 to 14 at Shougang Park, featuring nearly 20 conferences, forums, and related activities [1]. - The theme for this year's fair is "Intelligent Leadership for a Healthy Life," continuing the permanent theme of "Global Services, Shared Health" [1]. Group 2: Exhibition Highlights - The exhibition will include two main experience zones: "Intelligent Medical Cloud Matrix" and "Universal Health Service Matrix," showcasing advanced healthcare technologies and services [2][3]. - Major global companies, including GE Healthcare, Siemens Healthineers, and AstraZeneca, will participate, with a 54% participation rate from Fortune 500 companies and a 53% international participation rate [1]. Group 3: AI and Health Innovations - The "Intelligent Medical Cloud Matrix" will highlight a national AI application pilot project approved in Beijing, demonstrating 15 key processes in precision diagnosis and biomedicine AI development [2]. - Attendees will have the opportunity to experience AI diagnostic tools, such as cardiovascular diagnostic models and AI cameras for eye examinations [2]. Group 4: Health Management and Services - The "Universal Health Service Matrix" will focus on health management, elderly care, and traditional Chinese medicine, showcasing collaborative achievements between medical institutions and enterprises [3]. - The event will feature a health lecture series covering topics like weight management and mental health, providing accessible health education [3]. Group 5: Research and Collaboration - A series of significant research outcomes and signing projects will be announced, including the release of influential reports in the health sector [4]. - The event will facilitate discussions on technological innovation, health industry development, and international cooperation in healthcare [4]. Group 6: Focus on Beijing Service Brand - The exhibition will prominently feature "Beijing Service" brand cases, including innovative medical devices and significant investments in healthcare by companies like AstraZeneca [5]. - A dedicated negotiation area will be established to enhance supply-demand matching and accelerate the transformation of innovative technologies [5].

Core Insights - The article discusses the "Action Plan" issued by the Zhejiang Provincial Health Commission and 10 other departments to accelerate the high-quality development of "Artificial Intelligence + Healthcare" from 2025 to 2027 [1] Group 1: Action Plan Objectives - The plan aims to establish a national-level artificial intelligence medical application base, focusing on high standards and comprehensive empowerment of the healthcare sector and life health industry [1] - By 2027, the goal is to fully establish the national AI medical application base, centered around the Anzheng Children's Medical Model, and to cultivate over 50 high-quality industry-specific corpora and specialized models [1] Group 2: Key Targets and Innovations - The plan targets breakthroughs in over 10 core medical AI technologies and the development of more than 100 key healthcare scenarios across six fields: public, doctors, hospitals, research, industry, and government [1] - It aims to foster a number of innovative medical AI enterprises and multidisciplinary talents, creating a comprehensive innovation chain, service chain, and industrial chain for medical AI [1] Group 3: Collaborative Network - The initiative seeks to form a nationwide collaborative network involving government, enterprises, research institutions, and medical entities to enhance the integration and application of AI in healthcare [1]

经济观察网浙江省卫生健康委员会等10部门印发《浙江省加快推动"人工智能+医疗健康"高质量发展行 动计划(2025—2027年)》。其中提到，打造多模态医疗行业大模型，建设全自主AI研发框架，形成共性 模型服务能力。开发覆盖医疗服务、健康管理、公共卫生、药械研发、行业治理等一批专病专科模型和 医疗智能体。聚焦人工智能数据与应用、脑机接口、新药创制等领域部署实施重大科技专项，加强多模 态人工智能、具身智能与医学、药学交叉领域的科研布局。鼓励科研机构加强医学人工智能跨学科合 作，形成一批具有全球影响力的科研成果。 ...